Trials / Conditions / Drug Interaction Potentiation

Drug Interaction Potentiation

27 registered clinical trials studyying Drug Interaction Potentiation.

Status	Trial	Sponsor	Phase
Completed	Study to Evaluate Pharmacokinetic Drug Interactions and Safety of Ilaprazole and Aceclofenac NCT05558150	Il-Yang Pharm. Co., Ltd.	Phase 1
Completed	Study to Evaluate Pharmacokinetic Drug Interactions and Safety of Naproxen, Aceclofenac, Celecoxib and Ilapraz NCT05237297	Il-Yang Pharm. Co., Ltd.	Phase 1
Completed	Doravirine, Rifapentine and Isoniazid Interaction NCT03886701	Walter K. Kraft	Phase 1
Completed	Drug-Drug Interactions of Grazoprevir/Elbasvir in Taiwan NCT03706222	National Cheng-Kung University Hospital	—
Completed	Study to Evaluate the Effect of Rabeprazole on the Pharmacokinetics of Vadadustat NCT03789032	Akebia Therapeutics	Phase 1
Completed	Drug-Drug Interaction Study of Vadadustat With Cyclosporine, Probenecid and Rifampin NCT03801746	Akebia Therapeutics	Phase 1
Completed	Drug-Drug Interaction Study of Vadadustat With Digoxin, Adefovir and Furosemide NCT03801759	Akebia Therapeutics	Phase 1
Completed	Drug-Drug Interaction Study of Vadadustat With Rosuvastatin, Sulfasalazine, Pravastatin, Atorvastatin and Simv NCT03801733	Akebia Therapeutics	Phase 1
Completed	A Fixed-Sequence, Drug-Drug Interaction Study Between Multiple Oral Doses of Inarigivir Soproxil and a Single NCT03493698	F-star Therapeutics, Inc.	Phase 1
Completed	Mifepristone Drug-Drug Interaction Study With CYP3A Inhibitor NCT03259542	Corcept Therapeutics	Phase 1
Completed	Open-label, Single Center, Non-randomized, Fixed Sequence Phase 1 Drug-drug Interaction Study With LEO 32731 a NCT03126578	LEO Pharma	Phase 1
Completed	Improving Drug Safety in Emergency Patients -a Randomized Controlled Trial NCT03123640	Diakonhjemmet Hospital	N/A
Completed	Study to Evaluate Pharmacokinetic Drug Interactions and Safety of Clarithromycin, Amoxicillin and Ilaprazole NCT02998437	Il-Yang Pharm. Co., Ltd.	Phase 1
Completed	Pharmacokinetic Interaction Between Trospium With an Inhibitor of OCT1 and of P-gp in Subjects Genotyped for O NCT03011463	Dr. R. Pfleger Chemische Fabrik GmbH	Phase 1
Completed	A Drug-Drug Interaction Study of N91115 +/- Rifampin in Healthy Adult Subjects NCT02500667	Nivalis Therapeutics, Inc.	Phase 1
Completed	Pharmacogenetic Testing Among Home Health Patients NCT02378220	Genelex Corporation	N/A
Completed	Pharmacokinetic Interaction Study of Dapoxetine 30mg and Mirodenafil 100mg NCT02485041	SK Chemicals Co., Ltd.	Phase 1
Completed	YouScript IMPACT Registry NCT02191358	Genelex Corporation	—
Completed	Effect of Everolimus on the Pharmacokinetics of Tacrolimus in Renal Transplant Patients NCT02077556	National Taiwan University Hospital	Phase 4
Completed	Pharmacokinetic Interaction Study of Dapoxetine 30mg and Mirodenafil 50mg NCT02485028	SK Chemicals Co., Ltd.	Phase 1
Completed	Analysis of Cisatracurium Consumption in Balanced Anesthesia With 1% Sevoflurane, and With Only Sevoflurane, U NCT01736371	Tianjin Medical University General Hospital	N/A
Completed	A Drug-Drug Interaction Study of Digoxin and PA21 NCT01477411	Vifor Pharma	Phase 1
Completed	A Drug-Drug Interaction Study of Warfarin and PA21 NCT01477424	Vifor Pharma	Phase 1
Completed	Ranitidin Versus Omeprazole in Patients Taking Clopidogrel NCT01896557	University of Sao Paulo General Hospital	Phase 4
Completed	Drug Drug Interactions of Aspirin and P2Y12-inhibitors NCT01369186	Medical University of Vienna	Phase 4
Completed	A Drug-Drug Interaction Study of Losartan and PA21 NCT01324752	Vifor Pharma	Phase 1
Completed	Drug-drug Interaction Study in Healthy Male Volunteers Following the Administration of Pantoprazole and Rosuva NCT01146483	Centre hospitalier de l'Université de Montréal (CHUM)	Phase 1